Results 111 to 120 of about 3,234,483 (284)

On-line monitoring of downstream bioprocesses

open access: yesCurrent Opinion in Chemical Engineering, 2016
Downstream bioprocessing can benefit significantly from using on-line monitoring methods for surveillance, control and optimisation.
Roch, Patricia, Mandenius, Carl-Fredrik
openaire   +3 more sources

Aggressive prostate cancer is associated with pericyte dysfunction

open access: yesMolecular Oncology, EarlyView.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero   +11 more
wiley   +1 more source

Development of system of on-line monitoring, fault diagnosis and prewarning for insulation of mine-used dry-type transformer

open access: yesGong-kuang zidonghua, 2013
In view of problems that monitoring variable is single and real-time status of insulation of mine-used dry-type transformer cannot be reflected existed in traditional monitoring method of mine-used dry-type transformer because it uses thermocouple to ...
WAN Zhi-qiang   +4 more
doaj   +1 more source

ACIDES: on-line monitoring of forward genetic screens for protein engineering. [PDF]

open access: yesNat Commun, 2023
Nemoto T   +6 more
europepmc   +1 more source

Plasma extrachromosomal circular DNA as a biomarker in EGFR‐targeted therapy of non‐small cell lung cancer

open access: yesMolecular Oncology, EarlyView.
Detection of extrachromosomal circular DNA (eccDNA) in plasma samples from EGFR‐mutated non‐small cell lung cancer patients. Plasma was collected before and during treatment with the EGFR‐tyrosine kinase inhibitor osimertinib. Plasma eccDNA was detected in all cancer samples, and the presence of the EGFR gene on eccDNA serves as a potential biomarker ...
Simone Stensgaard   +5 more
wiley   +1 more source

MgII Line Variability of High Luminosity Quasars

open access: yes, 2008
We monitored five high-luminosity quasars with lambda L_{3000A} > 10^45 erg s^-1 at 0.4 < z < 0.6 to measure flux variability of the MgII 2798 line and explore feasibility of reverberation mapping using MgII. Over the two year monitoring program, imaging
Jong-Hak Woo, Maza, Maza, Maza, Webb
core   +1 more source

Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker

open access: yesMolecular Oncology, EarlyView.
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece   +18 more
wiley   +1 more source

CDK11 inhibition induces cytoplasmic p21WAF1 splice variant by p53 stabilisation and SF3B1 inactivation

open access: yesMolecular Oncology, EarlyView.
CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir   +12 more
wiley   +1 more source

In-line monitoring of protein concentration with MIR spectroscopy during UFDF. [PDF]

open access: yesEng Life Sci, 2023
Milewska A   +4 more
europepmc   +1 more source

Liquid biopsy epigenetics: establishing a molecular profile based on cell‐free DNA

open access: yesMolecular Oncology, EarlyView.
Cell‐free DNA (cfDNA) fragments in plasma from cancer patients carry epigenetic signatures reflecting their cells of origin. These epigenetic features include DNA methylation, nucleosome modifications, and variations in fragmentation. This review describes the biological properties of each feature and explores optimal strategies for harnessing cfDNA ...
Christoffer Trier Maansson   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy